QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes 期刊论文 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 卷号: 489, 期号: 1, 页码: 14-20 作者:  Wang, Hongbin;  Quan, Haitian;  Lou, Liguang 收藏  |  浏览/下载：24/0  |  提交时间：2019/01/08 Antagonism  AKT  BRAF  Dabrafenib  Sorafenib   Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-Raf(V600E) inhibitors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 7, 页码: 1059-1068 作者:  Wang, Gui-min;  Wang, Xiang;  Zhu, Jian-ming;  Guo, Bin-bin;  Yang, Zhuo 收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08 B-Raf(V600E) inhibitor  anticancer  vemurafenib  deazapurine  fragment reassembly  molecular docking  structure-activity relationship   A branch-migration based fluorescent probe for straightforward, sensitive and specific discrimination of DNA mutations 期刊论文 NUCLEIC ACIDS RESEARCH, 2017 Xiao, Xianjin; Wu, Tongbo; Xu, Lei; Chen, Wei; Zhao, Meiping 收藏  |  浏览/下载：103/0  |  提交时间：2017/12/03 MOLECULAR BEACONS  SINGLE  CANCER  AMPLIFICATION  HYBRIDIZATION  SELECTIVITY  ENZYME  PCR   Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature 期刊论文 2017, 卷号: 70, 期号: 12, 页码: 1079-1083 作者:  Wang, Leiming;  Sun, Jian;  Li, Zhuo;  Chen, Li;  Fu, Yongjuan 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 BRAF V600E  IDH mutation  glioblastoma  gliosarcoma   Association between BRAF(V600E) mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma 期刊论文 2017, 卷号: 13, 期号: 3, 页码: 1595-1600 作者:  Lu, Hai-Zhen;  Qiu, Tian;  Ying, Jian-Ming;  Lyn, Ning 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 solitary papillary thyroid micro-carcinoma  B-Raf proto-oncogene serine/threonine kinase mutation  clinicopathological features  autoimmune thyroiditis  prognosis